The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

Biomaterials

Volumn 21, Issue 23, 2000, Pages 2475-2490

  Jain, Rajeev A ^a  

^a NanoSystems   (United States)

Author keywords

Biodegradable; Bioresorbable; Poly(lactide co glycolide) (PLGA)

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; COPOLYMERS; DRUG THERAPY; ENCAPSULATION; POLYESTERS; PROTEINS; VACCINES;

BIOABSORPTION; MICROMOLECULES; PEPTIDES; POLYGLYCOLIDE; POLYLACTIDE;

BIOMATERIALS;

NANOPARTICLE; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; POLYMER;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; DISPERSION; DRUG DELIVERY SYSTEM; EMULSION; IMPLANT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

EID: 0034580371     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00115-0     Document Type: Article

References (191)

1. Jalil R., Nixon J.R. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules. problems associated with preparative techniques and release properties J Microencapsulation. 7:1990;297-325.
2. Tice T.R., Tabibi E.S. Parenteral drug delivery. injectables Kydonieus A. Treatise on controlled drug delivery. fundamentals optimization, applications:1991;315-339 Marcel Dekker, New York.
3. Wu X.S. Synthesis and properties of biodegradable lactic/glycolic acid polymers. Wiseet al. Encyclopedic Handbook of Biomaterials and Bioengineering. 1995;1015-1054 Marcel Dekker, New York.
4. Wu X.S. Preparation, characterization, and drug delivery applications of mucrospheres based on biodegradable lactic/glycolic acid polymers. Wiseet al. Encyclopedic handbook of biomaterials and bioengineering. 1995;1151-1200 Marcel Dekker, New York.
5. Lewis D.H. Controlled release of bioactive agents from lactide/glycolide polymers. Chasin M., Langer R. Biodegradable polymers as drug delivery systems. 1990;1-41 Marcel Dekker, New York.
6. Heller J. Controlled release of biologically active compounds from bioerodible polymers. Biomaterials. 1:1980;51-57.
7. Heller J. Biodegradable polymers in controlled drug delivery. Crit Rev Therap Drug Carrier System. 1(1):1984;39-90.
8. Heller J. Controlled drug release from poly(ortho esters) - a surface eroding polymer. J Control Rel. 2:1985;167-177.
9. Tice T.R., Cowsar D.R. Biodegradable controlled-release parenteral systems. Pharm Technol. 11:1984;26-35.
10. Arshady R. Preparation of biodegradable microspheres and microcapsules. 2. Polylactides and related polyesters J Control Rel. 17:1991;1-22.
11. Brannon-Peppas L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm. 116:1995;1-9.
12. Kitchell J.P., Wise D.L. Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems. Methods Enzymol. 112:1985;436-448.
13. Cohen S., Alonso M.J., Langer R. Novel approaches to controlled-release antigen delivery. Int J Technol Assessment Health Care. 10(1):1994;121-130.
14. Vert M. The complexity of PLAGA-based drug delivery systems. Proceedings of the International Conference on Advances in Controlled Delivery, Baltimore, MD, 1996. p. 32-6.
15. Zhao Z., Leong K.W. Controlled delivery of antigens and adjuvants in vaccine development. J Pharm Sci. 85(12):1996;1261-1270.
16. Eldridge J.E., Staas J.K., Chen D., Marx P.A., Tice T.R., Gilley R.M. New advances in vaccine delivery systems. Sem Hematol. 30(4):1993;16-24.
17. Tice T, Gilley R, Mason D, Ferrell T, Staas J, Love D, McRae A, Dahlström A, Ling E, Jacob E, Setterstrom J. Site-directed drug delivery with biodegradable microspheres. Proceedings of the International Conference on Advances in Controlled Delivery, Baltimore, MD, 1996. p. 30-1.
18. Gilding D.M., Reed A.M. Biodegradable polymers for use in surgery. Poly(glycolic)/poly(lactic acid) homo and copolymers. Polymer. 20:1979;1459-1464.
19. Jamshidi K., Hyon S.H., Ikada Y. Thermal characterization of polylactides. Polymer. 29:1988;2229-2234.
20. Thies C., Bissery M.C. Biodegradable microspheres for parenteral administration. Lim F. Biomedical applications of microencapsulation. 1984;53-74 CRC Press, Boca Raton, FL.
21. Raghuvanshi R.S., Singh M., Talwar G.P. Biodegradable delivery system for single step immunization with tetanus toxoid. Int J Pharm. 93:1993;R1-R5.
22. Brady J.M., Cutright D.E., Miller R.A., Battistone G.C. Resorption rate, route of elimination and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res. 7:1973;155-166.
23. Fong J.W. Microencapsulation by solvent evaporation and organic phase separation process. Hsieh D. Controlled release systems. fabrication technology vol. 1:1988;81-108 CRC Press, Boca Raton, FL.
24. Wada R., Hyon S.-H., Ike O., Watanabe S., Shimizu Y., Ikada Y. Preparation of lactic acid oligomer microspheres containing anti-cancer drug by o/o type solvent evaporation process. Polym Mater Sci Engng. 59:1988;803-806.
25. Cavalier M., Benoit J.P., Thies C. The formation and characterization of hydrocortisone-loaded poly((±)-lactide) microspheres. J Pharm Pharmacol. 38:1986;249-253.
26. Tsai D.C., Howard S.A., Hogan T.F., Malanga C.J., Kandzari S.J., Ma J.K.H. Preparation and in vitro evaluation of polylactic acid-mitomycin C microcapsules. J Microencapsul. 3(3):1986;181-193.
27. Alonso M.J., Gupta R.K., Min C., Siber G.R., Langer R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine. 12(4):1994;299-306.
28. Singh M., Singh O., Talwar G.P. Biodegradable delivery system for a birth control vaccine. immunogenicity studies in rats and monkeys Pharm Res. 12(11):1995;1796-1800.
29. Cohen S., Yoshioka T., Lucarelli M., Hwang L.H., Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res. 8(6):1991;713-720.
30. Conway BR, Alpar HO, Lewis DA, Studies on the optimisation of loading and release kinetics of interferon- γ from polylactide microspheres. Proceedings of the International Symposium on Controlled Release of Bioactive Materials, vol. 21, 1994. p. 284-5.
31. Alpar HO, Conway BR, Bowen JC. The effects of formulation of PLA microspheres on immune responses: an in vivo study. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 564-5.
32. Ogawa Y., Yamamoto M., Okada H., Yashiki T., Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem Pharm Bull. 36(3):1988;1095-1103.
33. Okada H., Heya T., Ogawa Y., Shimamoto T. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. Pharm Exp Ther. 244(2):1988;744-750.
34. Toguchi H. Formulation study of leuprorelin acetate to improve clinical performance. Clin Ther. 14(Suppl. A):1992;121-130.
35. Okada H., Doken Y., Ogawa Y., Toguchi H. Preparation of a three-month depot injectable microspheres of leuproline acetate using biodegradable polymers. Pharm Res. 11(8):1994;1143-1147.
36. Kamijo A., Kamei S., Saikawa A., Igari Y., Ogawa Y. In vitro release test system of (D,L-lactic-glycolic) acid copolymer microcapsules for sustained release of LHRH agonist (leuprorelin). J Control Rel. 40:1996;269-276.
37. Okada H., Doken Y., Ogawa Y. Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate. J Pharm Sci. 85(10):1996;1044-1048.
38. O'Hagen D.T., Jeffery H., Roberts M.J.J., McGee J.P., Davis S.S. Controlled release microparticles for vaccine development. Vaccine. 9:1991;768-771.
39. Challacombe S.J., Rahman D., Jeffery H., Davis S.S., O'Hagan D.T. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology. 76:1992;164-168.
40. Jeffery H., Davis S.S., O'Hagan D.T. The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res. 10(3):1993;362-368.
41. O'Hagen D.T., McGee J.P., Holmgren J., Mowat A.M., Donachie A.M., Mills K.H.G., Gaisford W., Rahman D., Challacombe S.J. Biodegradable microparticles for oral immunization. Vaccine. 11(2):1993;149-153.
42. O'Hagen D.T., Jeffery H., Davis S.S. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine. 11(9):1993;965-969.
43. Maloy K.J., Donachie A.M., O'Hagen D.T., Mowat A.M. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology. 81:1994;661-667.
44. Sharif S, Wheeler AW, O'Hagan DT. Investigation of the structural and immunologic integrity of an allergen entrapped in poly(lactide-co-glycolide) microparticles. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 21, 1994. p. 294-5.
45. Sharif S., Wheeler A.W., O'Hagan D.T. Biodegradable microparticles as a delivery system for the allergens of Dermatophagoides pteronyssinus (house dust mite). I. Preparation and characterization of microparticles Int J Pharm. 119:1995;239-246.
46. O'Hagen D.T., McGee J.P., Lindblad M., Holmgren J. Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization. Int J Pharm. 119:1995;251-255.
47. Singh M, Li X-M, Qiu H, Zamb T, Wang CY, O'Hagan DT. Residual polyvinyl alcohol content in polylactide-co-glycolide microparticles prepared by solvent evaporation method. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 367-8.
48. Alonso M.J., Cohen S., Park T.G., Gupta R.K., Siber G.R., Langer R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm Res. 10(7):1993;945-953.
49. Russell-Jones GL, Jeffery H. In vitro characterization of biodegradable microparticles for oral antigen delivery. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 21, 1994. p. 873-4.
50. Kende M, Yan C, Rill W, Malli R, Tammariello R, Hewetson J, Reduction of anti-ricin immunization-time by vaccine incorporated into small polylactide-co-glycolide (PLG) microparticle (MP). Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 21, 1994. p. 875-6.
51. Cleland J.L., Powell M.F., Lim A., Barrón L., Berman P.W., Eastman D.J., Nunberg J.H., Wrin T., Vennari J.C. Development of a single-shot subunit vaccine for HIV-1. AIDS Res Human Retroviruses. 10(Suppl. 2):1994;S21-S26.
52. Uchida T., Martin S., Foster T., Wardley R.C., Grimm S. Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin. Pharm Res. 11(7):1994;1009-1015.
53. Uchida T., Goto S. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation. particle size study Biol Pharm Bull. 17(9):1994;1272-1276.
54. Coombes AGA, Lavelle EC, Jenkins PG, Davis SS. Pulsed and sustained immune response following a single dose of a model antigen associated with resorbable microparticles. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 560-1.
55. Sah H., Toddywala R., Chien Y.W. Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant. J Control Rel. 35:1995;137-144.
56. Raghuvanshi RS, Ganga S, Misra A, Mehta S, Singh O, Panda AK. Stabilization of tetanus toxoid against dichloromethane. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 859-60.
57. Hilbert A, Kissel T, Fritzsche U, Reers M. Release of influenza vaccine from biodegradable microspheres and microencapsulated liposomes. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 79-80.
58. Conway BR, Eyles JE, Alpar HO. Immune response to antigen in microspheres of different polymers. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 335-6.
59. Ganga S, Singh O. Controlled release of hCG birth control vaccine using biodegradable microspheres. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 353-4.
60. Sturesson C, Artursson P, Svensson L, Carlfors J. Preparation and characterization of hydrophobic PLG microspheres suitable for oral vaccination with rotavirus. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 515-6.
61. Hilfinger JM, Tsume Y, Beer S, Davidson B, Crison JR, Amidon GL. Extended release of recombinant adenovirus from PLGA microspheres. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 915-6.
62. Cheng A.-C., Gupta R.K. Stabilization of tetanus toxoid in poly(D,L-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J Pharm Sci. 85(2):1996;129-132.
63. Crotts G, Parks TG. Analysis of erosion induced surface expansion of poly(lactic-co-glycolide) microparticles. Proceedings of the International Conference on Advances in Controlled Delivery, Baltimore, MD, 1996. p. 75-6.
64. Sah H., Toddywala R., Chien Y.W. Biodegradable microcapsules prepared by a w/o/w technique. effects of shear force to make primary w/o emulsion on their morphology and protein release J Microencapsul. 12(1):1995;59-69.
65. + liberated from hydrolytic cleavage of polyester microcapsules on their permeability and degradability. J Pharm Sci. 84(1):1995;1353-1359.
66. Crotts G., Park T.G. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J Control Rel. 35:1995;91-105.
67. Sah H, Chien YW. Role of low-molecular-weight polylactide and its copolymer in the acceleration of hydrolysis of PLGA(75 : 25) microcapsules.Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 776-7.
68. Sah H., Toddywala R., Chien Y.W. The influence of biodegradable microcapsule formulations on the controlled release of a protein. J Control Rel. 30:1994;201-211.
69. Park TG, Crotts G. Microencapsulation of capsaicin using solvent extraction and solvent evaporation processes. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 355-6.
70. Sharif S., O'Hagan D.T. A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles. Int J Pharm. 115:1995;259-263.
71. Reich G. Protein properties affecting their entrapment and release characteristics from PLA/PLGA microspheres. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 546-7.
72. Benoit MA, Baras B, Youan BBC, Riveau G, Gillard J, Capron A. Poly( ε -caprolactone) microparticles as vaccine carrier. Proceedings of the International Conference on Advances in Controlled Delivery, Baltimore, MD, 1996. p. 69-70.
73. Heya T., Okada H., Ogawa Y., Toguchi H. In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(D,L-lactic/glycolic acid) microspheres. J Pharm Sci. 83(5):1994;636-640.
74. Heya T., Mikura Y., Nagai A., Miura Y., Futo T., Tomida Y., Shimizu H., Toguchi H. Controlled release of thyrotropin releasing hormone from microspheres. evaluation of release profiles and pharmacokinetics after subcutaneous administration J Pharm Sci. 83(6):1994;798-801.
75. Cleland JL, Duenas ET, Yang J, Chu H, Mukku V, Mac A, Roussakis M, Yeung D, Brooks D, Maa Y-F, Hsu C, Jones AJS. One month continuous release recombinant human growth hormone-PLGA formulations. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 149-50.
76. Cleland JL, Yang J. In vitro release of bioactive recombinant human interferon- γ from PLGA microspheres. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 518-9.
77. Lu W., Park T.G. Protein release from poly(lactic-co-glycolic acid) microspheres. protein stability problems PDA J Pharm Sci Technol. 49(1):1995;13-19.
78. Blanco-Príeto M.J., Leo E., Delie F., Gulik A., Couvreur P., Fattal E. Study of the influence of several stabilizing agents on the entapment and in vitro release of pBC 264 from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method. Pharm Res. 13(7):1996;1127-1129.
79. Kissel T., Li Y.X., Volland C., Görich S., Koneberg R. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks. J Control Rel. 39:1996;315-326.
80. Esposito E., Cortesi R., Bortolotti F., Manegatti E., Nastruzzi C. Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors. Int J Pharm. 129:1996;263-273.
81. Cleland J.L., Jones A.J.S. Stable formulations of recombinant human growth hormone and interferon-. γ for microencapsulation in biodegradable microspheres Pharm Res. 13(10):1996;1464-1475.
82. Cleland J.L., Mac A., Boyd B., Yang J., Duenas E.T., Yeung D., Brooks D., Hsu C., Chu H., Mukku V., Jones A.J.S. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res. 14(4):1997;420-425.
83. Duenas ET, Yang J, Jones AJS, Cleland JL. Development of a new in vitro release method for microencapsulated proteins. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 516-7.
84. Yan C., Resau J.H., Hewetson J., West M., Rill W.L., Kende M. Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique. J Control Rel. 32:1994;231-241.
85. Soriano I., Evora C., Llabrés M. Preparation and evaluation of insulin-loaded poly(D,L-lactide) microspheres using an experimental design. Int J Pharm. 142:1996;135-142.
86. Blanco-Prieto MJ, Fattal E, Durieux C, Roques BP, Couvreur P. Brain delivery of the cholecystokinin agonist pBC 264 using PLG microspheres. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 853-4.
87. Erden N, Celebi N. Preparation of salbutamol sulphate-poly(lactic-co-glycolic acid) microspheres by double emulsion method. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 21, 1994. p. 180-1.
88. Labhasetwar V., Underwood T., Gallagher M., Murphy G., Langberg J., Levy R.J. Sotalol controlled-release systems for arrhythmias. in vitro characterization, in vivo drug disposition, and electrophysiologic effects J Pharm Sci. 83(2):1994;156-164.
89. Schugens C., Laruelle N., Nihant N., Grandfils C., Jérôme R., Teyssié P. Effect of the emulsion stability on the morphology and porosity of semicrystalline poly l-lactide microparticles prepared by w/o/w double emulsion-evaporation. J Control Rel. 32:1994;161-176.
90. Crotts G, Park TG. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 81-2.
91. Mandal TK, Shakleton M, Washington L, Onyebueke E, Penson T. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 3305-6.
92. Kim JH, Kwon IC, Kim YH, Sohn YT, Jeong SY. The effect of the stability of the multiple emulsion on the preparation of polylactide microspheres containing a hydrophilic drug. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 341-2.
93. Van Hamont JE, Madden EF, Wood BA, Jacob E, Setterstrom JA. Evaluation of solvent extraction and solvent evaporation procedures for production of tobramycin-releasing microspheres. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 365-6.
94. Erden N., Celebi N. Factors influencing release of salbutamol sulphate from poly(lactide-co-glycolide) microspheres prepared by water-in-oil-in-water emulsion technique. Int J Pharm. 137:1996;57-66.
95. Mandal T.K., Tanjarla S. Preparation of biodegradable microcapsules of zidovudine using solvent evaporation. effect of the modification of aqueous phase Int J Pharm. 137:1996;187-197.
96. Ghaderi R., Sturesson C., Carlfors J. Effect of preparative parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres made by the double emulsion method. Int J Pharm. 141:1996;205-216.
97. Akhtar S., Lewis K.J. Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres. Int J Pharm. 151:1997;57-67.
98. El-Baseir M.M., Phipps M.A., Kellaway I.W. Preparation and subsequent degradation of poly(L-lactic acid) microspheres suitable for aerosolisation. a physico-chemical study Int J Pharm. 151:1997;145-153.
99. Takada S., Kurokawa T., Miyazaki K., Iwasa S., Ogawa Y. Sustained release of a water-soluble GP IIb/IIIa antagonist from copoly(D,L-lactic/glycolic)acid microspheres. Int J Pharm. 146:1997;147-157.
100. Edelman R., Russell R.G., Losonsky G., Tall B.D., Tacket C.O., Levine M.M., Lewis D.H. Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly(lactide-co-glycolide). Vaccine. 11(2):1993;155-158.
101. Mandal TK, Shakleton M, Trinh KB, Le TN. Application of a novel phase separation technique for the encapsulation of diltiazem and metoprolol. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 772-3.
102. Nihant N., Grandfils C., Jérôme R., Teyssié P. Microencapsulation by coacervation of poly(lactide-co-glycolide) IV. Effect of the processing parameters on coacervation and encapsulation. J Control Rel. 35:1995;117-125.
103. Csernus V.J., Szende B., Schally A.V. Release of peptides from sustained delivery systems (microcapsules and microparticles) in vivo. Int J Peptide Protein Res. 35:1990;557-565.
104. Schally A.V., Redding T.W. Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy. Investigation in the rat prostate cancer model Proc Natl Acad Sci. 82:1985;2498-2502.
105. Sanders L.M., Kent J.S., McRae G.I., Vickery B.H., Tice T.R., Lewis D.H. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(D,L-lactide-co-glycolide) microspheres. J Pharm Sci. 73(9):1984;1294-1297.
106. Hausberger A.G., Kenley R.A., DeLuca P.P. Gamma irradiation effects on molecular weight and in vitro degradation of poly(D,L-lactide-co-glycolide) microparticles. Pharm Res. 12(6):1995;851-856.
107. Leelarasamee N, Howard SA, Malanga CJ, Luzzi LA, Hogan TF, Kandzari SJ, Ma JKH. Kinetics of drug release from polylactic acid-hydrocortisone microcapsules. J Microencapsul 3:171-9.
108. Thomasin C., Merkle H.P., Gander B.A. Physico-chemical parameters governing protein microencapsulation into biodegradable polyesters by coacervation. Int J Pharm. 147:1997;173-186.
109. Pettit D, Pankey S, Nightlinger N, Disis M, Gombotz W. GM-CSF encapsulated in PLGA microspheres for vaccine adjuvancy. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 857-8.
110. Nihant N., Stassen S., Grandfils C., Jérôme R., Teyssié P., Goffinet G. Microencapsulation by coacervation of poly(lactide-co-glycolide) III. Characterization of the final microspheres. Polym Int. 34:1994;289-299.
111. Esparza I., Kissel T. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine. 10(10):1992;714-720.
112. Fong JW, Process for preparation of microcapsules. U.S. Patent 4,166,800, 1997.
113. Ruiz J.M., Tissier B., Benoit J.P. Microencapsulation of peptide. a study of the phase separation of poly(D,L-lactic acid-co-glycolic acid) copolymers 50/50 by silicone oil Int J Pharm. 49:1989;69-77.
114. Takada S., Uda Y., Toguchi H., Ogawa Y. Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers. PDA J Pharm Sci Technol. 49(4):1995;180-184.
115. Wagenaar B.W., Müller B.W. Piroxicam release from spray-dried biodegradable microspheres. Biomaterials. 15(1):1994;49-54.
116. Wise D.L., McCormick G.J., Willet G.P., Anderson L.C. Sustained release of an antimalarial drug using a co-polymer of glycolic/lactic acid. Life Sciences. 19:1976;867-874.
117. Bodmeier R., McGinity J.W. Poly(lactic acid) microcapsules containing quinidine base and quinidine sulfate prepared by solvent evaporation technique. III. Morphology of the microspheres during dissolution studies. J Microencapsul. 5:1988;325-330.
118. Tamber H, Merkle HP, Steward MW, Partidos CD, Gander B. In vitro release of a synthetic measles virus antigen from PLGA microspheres. Proceedings of the International Conference on Advances in Controlled Delivery, Baltimore, MD, 1996. p. 129-30.
119. Castelli F., Conti B., Conte U., Puglisi G. Effect of molecular weight and storage times on tolmetin release from poly-D,L-lactide microspheres to lipid model membrane. A calorimetric study. J Control Rel. 40:1996;277-284.
120. Dickinson P.A., Kellaway I.W., Taylor G., Mohr D., Nagels K., Wolff H.-M. In vitro and in vivo release of estradiol from an intra-muscular microsphere formulation. Int J Pharm. 148:1997;55-61.
121. Men Y, Corradin G, Thomasin C, Merkle HP, Gander B. Immunopotentiation of a synthetic antigen by incorporation into biodegradable microspheres. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 21, 1994. p. 50-1.
122. Lee HK, Park JH, Kwon KC. Double walled microparticles for HBV single shot vaccine. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 333-4.
123. Khan MA, Healy MS, Bernstein H. Low temperature fabrication of protein loaded microspheres. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 19, 1992. p. 518-9.
124. ® human growth hormone PLGA microspheres produced using different solvents. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol 23, 1996. p. 835-6.
125. Johnson O.L., Jaworowicz W., Cleland J.L., Bailey L., Charnis M., Duenas E., Wu C., Shepard D., Magil S., Last T., Jones A.J.S., Putney S.D. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm Res. 14(6):1997;730-735.
126. Yeh M.-K., Davis S.S., Coombes A.G.A. Improving protein delivery from microparticles using blends of poly(D,L lactide-co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers. Pharm Res. 13(11):1996;1693-1698.
127. Song C, Labhasetwar V, Guzman L, Topol E, Levy RJ. Dexamethasone-nanoparticles for intra-arterial localization in restenosis in rats. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 444-5.
128. Dawson GF, Halbert GW. Production of sub 100 nm poly(lactide-co-glycolide) nanoparticles utilising a central rotational experimental design. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 424-5.
129. Müller R.H., Maaen S., Weyhers H., Specht F., Lucks J.S. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharm. 138:1996;85-94.
130. Leroux J.C., Allémann E., De Jaeghere F., Doelker E., Gurny R. Biodegradable nanoparticles-From sustained release formulations to improved site specific drug delivery. J Control Rel. 39:1996;339-350.
131. Niwa T., Takeuchi H., Hino T., Kunou N., Kawashima Y. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control Rel. 25:1993;89-98.
132. Niwa T., Takeuchi H., Hino T., Kunou N., Kawashima Y. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. J Pharm Sci. 83(5):1994;727-732.
133. Niwa T., Takeuchi H., Hino T., Nohara M., Kawashima Y. Biodegradable submicron carries for peptide drugs. preparation of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system Int J Pharm. 121:1995;45-54.
134. Murakami H, Yoshino H, Mizobe M, Kobayashi M, Takeuchi H, Kawashima Y, Preparation of poly(D,L-lactide-co-glycolide) latex for surface-modifying material by a double coacervation method. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol 23, 1996. p. 361-2.
135. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 263:1994;1600-1603.
136. Stolnik S., Dunn S.E., Garnett M.C., Davis M.C., Coombes A.G.A., Taylor D.C., Irving M.P., Purkiss S.C., Tadros T.F., Davis S.S., Illum L. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res. 11(12):1994;1800-1808.
137. Dunn SE, Stolnik S, Garnett MC, Davis MC, Coombes AGA, Taylor DC, Irving MP, Purkiss SC, Tadros TF, Davis SS, Illum L. Biodistribution studies investigating poly(lactide-co-glycolide) nanospheres surface modified by novel biodegradable copolymers. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 21, 1994. p. 210-1.
138. Quintanar-Guerrero D, Fessi H, Allémann E, Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(D,L-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm 1996;143:133-41.
139. Murakami H., Kawashima Y., Niwa T., Hino T., Takeuchi H., Kobayashi M. Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(D,L-lactide-co-glycolide) nanoparticle. Int J Pharm. 149:1997;43-49.
140. Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy RJ. Nanoparticles for site specific delivery of U-86983 in restenosis in pig coronary arteries. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 182-3.
141. Némati F., Dubernet C., Fessi H., de Verdière A.C., Poupon M.F., Puisieux F., Couvreur P. Reversion of multidrug resistance using nanoparticles in vitro. influence of the nature of the polymer Int J Pharm. 138:1996;237-246.
142. Sanders L.M., Kell B.A., McRae G.I., Whitehead G.W. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants. influence of composition and molecular weight of polymer J Pharm Sci. 75(4):1986;356-360.
143. Heinrich N., Fechner K., Berger H., Lorenz D., Albrecht E., Rafler G., Schäfer H., Mehlis B. In vivo release of a GnRH agonist from a slow-release poly(lactide-glycolide) copolymer preparation. comparison in rat, rabbit and guinea-pig J Pharm Pharm. 43:1991;762-765.
144. Sharon A.C., Wise D.L. Development of drug delivery systems for use in treatment of narcotic addiction. Nat Inst Drug Abuse. 1980;194-213.
145. Gangadharam P.R.J., Kailasam S., Srinivasan S., Wise D.L. Experimental chemotherapy of tuberculosis using single dose treatment with isoniazid in biodegradable polymers. Br J Antimicrobial Chemotherapy. 33:1994;265-271.
146. Kailasam S., Wise D.L., Gangadharam P.R.J. Bioavailability and chemotherapeutic activity of clofazimine against Mycobacterium avium complex infections in beige mice following a single implant of a biodegradable polymer. Br J Antimicrobial Chemotherapy. 33:1994;273-279.
147. Kunou N, Ogura Y, Hashizoe M, Honda Y, Ikada, Y, Ota A, Hikida M, Kawashima Y, Biodegradable scleral implant for controlled intraocular delivery of ganciclovir. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 711-2.
148. Wang G., Tucker I.G., Roberts M.S., Hirst L.H. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide). Pharm Res. 13(7):1996;1059-1064.
149. Lin S.S., Ueng S.W., Liu S.J., Chan E.C., Chao E.K., Tsai C.H., Chen K.T., Wei F.C., Shih C.H. Development of biodegradable antibiotic delivery system. Clin Orthop. 5(362):1999;240-250.
150. Teupe C., Meffert R., Winckler S., Ritzerfeld W., Tormala P., Brug E. Ciprofloxacin-impregnated poly-L-lactic acid drug carrier. New aspects of a resorbable drug delivery system in local antimicrobial treatment of bone infections. Arch Orthop Trauma Surg. 112(1):1992;33-35.
151. Ramchandani M., Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50 : 50 implants. J Control Rel. 54(2):1998;167-175.
152. Lemmouchi Y., Schacht E., Kageruka P., De Deken R., Diarra B., Diall O., Geerts S. Biodegradable polyesters for controlled release of trypanocidal drugs. in vitro and in vivo studies Biomaterials. 19(20):1998;1827-1837.
153. Mandal TK, Lopez-Anaya A, Shakleton M. Release characteristic of zidovudine (AZT) from biodegradable matrices. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 770-1.
154. Schellhorn M, Buchholz B. Hydrolytic degradation kinetics of amorphous resorbable polymers. A study on the temperature dependency. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 226-7.
155. Mäder K, Bacic G, Domb A, Swartz HM. Characterization of microstructures in drug delivery systems by EPR spectroscopy. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 780-1.
156. Mäder K, Bacic G, Domb A, Langer R, Swartz HM. Noninvasive in vivo characterization of biodegradable polymers by EPR spectroscopy and NMR imaging. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 77-8.
157. Schmitt E.A., Flanagan D.R., Linhardt R.J. Degradation and release properties of pellets fabricated from three commerical poly(D,L-lactide-co-glycolide) biodegradable polymers. J Pharm Sci. 82(3):1993;326-329.
158. Tracy MA, Firouzabadian L, Zhang Y. Effects of PLGA end groups on degradation. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 786-7.
159. Schade A., Niwa T., Takeuchi H., Hino T., Kawashima Y. Aqueous colloidal polymer dispersions of biodegradable D,L-lactide/glycolide copolymer as basis for latex films. a new approach for the development of biodegradable depot systems Int J Pharm. 117:1995;209-217.
160. Song CX, Labhasetwar V, Levy RJ. Modulation of release rates from double-layer poly(lactic-co-glycolic acid) films for periadventital implants in restenosis. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 473-4.
161. Li S., Girod-Holland S., Vert M. Hydrolytic degradation of poly(D,L-lactic acid) in the presence of caffeine base. J Control Rel. 40:1996;41-53.
162. Ronneberger B, Kao WJ, Anderson JA, Kissel T. In vivo biocompatibility study of ABA copolymers. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 778-9.
163. Zhang Y, Zale S, Alukonis L, Bernstein H. Effects of metal salts on PLGA hydrolysis. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 83-4.
164. Hsu Y.-Y., Gresser J.D., Trantolo D.J., Lyons C.M., Gangadharam P.R.J., Wise D.L. Low-density poly(D,L-lactide-co-glycolide) foams for prolonged release of isoniazid. J Control Rel. 40:1996;293-302.
165. Hsu Y.-Y., Gresser J.D., Stewart R.R., Trantolo D.J., Lyons C.M., Simons G.A., Gangadharam P.R.J., Wise D.L. Mechanisms of isoniazid release from poly(D,L-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods. J Pharm Sci. 85(7):1996;706-713.
166. Lee SJ, Park YJ, Ha SJ, Kim DK, Yeom JL, Chung CP. Porous poly(L-lactide) membranes for guided tissue regeneration and drug delivery. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 232-3.
167. Whang K, Healy KE. Controlled release of protein from emulsion freeze-dried PLGA scaffolds. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 536-7.
168. Nakaoke R., Tabata Y., Ikada Y. Antibody production by administration of biodegradable granules incorporating antigen through different injection routes. J Control Rel. 40:1996;11-21.
169. Duggirala S.S., Rodgers J.B., DeLuca P.P. The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2. Pharm Dev Technol. 1(2):1996;165-174.
170. Shah N.H., Railkar A.S., Chen F.C., Tarantino R., Kumar S., Murjani M., Palmer D., Infeld M.H., Malick A.W. A biodegradable injectable implant for delivering micro and macromolecules using poly(lactic-co-glycolic) acid (PLGA) copolymers. J Control Rel. 27:1993;139-147.
171. Shively M.L., Coonts B.A., Renner W.D., Southard J.L., Bennett A.T. Physico-chemical characterization of a polymeric injectable implant delivery system. J Control Rel. 33:1995;237-243.
172. Dunn RL, Tipton AJ, Menardi EM. A biodegrdable in situ forming drug delivery system. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 18, 1991. p. 465.
173. Dunn RL, Tipton AJ, Yewey GL, Reinhart PC, Menardi EM, Rogers JA. An injectable implant delivery system for antimicrobial agents, Southard GL. American Association of Pharmaceutical Scientists, Western Regional Meeting, Reno, NV, 1992. p. 189-91.
174. Fujita S.M., Sherman J.M., Godowski K.C., Tipton A.J. Delivery of amikacin from an aerosoled biodegradable film. Pharm Res. 9(10):1992;S-187.
175. ™ drug delivery system. Pharm Res. 9(10):1992;S-73.
176. Tipton AJ, Fujita SM, Frank KR, Dunn RL. Release of naproxen from a biodegradable, injectable delivery system. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 19, 1992. p. 314.
177. Lowe BK, Norton RL, Keeler EL, Frank KR, Tipton, AJ. The effects of γ irradiation on poly(DL-lactide) as a solid and in N-methyl-2-pyrrolidone solutions. 19th Annual Meeting of the Society for Biomaterials, Birmingham, AL, 1993.
178. Frank K.R., Duysen E.G., Yewey G.L., Dunn R.L., Huffer W.E., Pieters R. Controlled release of bioactive growth factors from a biodegradable delivery system. Pharm Res. 11(10):1994;S-88.
179. ™ formulations for the management of postoperative pain. Pharm Res. 11(10):1994;S-318.
180. Duysen E.G., Whitman S.L., Krinick N.L., Fujita S.M., Yewey G.L. An injectable, biodegradable delivery system for antineoplastic agents. Pharm Res. 11(10):1994;S-88.
181. Knight SMG, Norton RL, Biodegradable bone wax formulations as release vehicles for antibiotics: in vitro testing. 20th Annual Meeting of the Society for Biomaterials, Boston, MA, 1994.
182. Dunn RL, Yewey GL, Duysen EG, Polson AM, Southard GL, In situ forming biodegradable polymeric implants for tissue regeneration. American Chemical Society Meeting, Washington, DC, 1994.
183. ™ polymer system. Portland Bone Symposium, Portland, OR, 1995.
184. Moore LA, Norton RL, Whitman SL, Dunn RL, An injectable biodegradable drug delivery system based on acrylic terminated poly( ε -caprolactone), 21st Annual Meeting of the Society for Biomaterials, San Francisco, CA, 1995.
185. Dunn R, Hardee G, Polson A, Bennett A, Martin S, Wardley R, Moseley W, Krinick N, Foster T, Frank K, Cox S. In situ forming biodegradable implants for controlled release veterinary applications. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 22, 1995. p. 91-2.
186. Polson A.M., Southard G.L., Dunn R.L., Polson A.P., Billen J.R., Laster L.L. Initial study of guided tissue regeneration in class II furcation defects after use of a biodegradable barrier. Int J Periodontics Restorative Dent. 15(1):1995;43-55.
187. Eliaz R, Kost J. Injectable system for in situ forming solid biodegradable protein delivery. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 23, 1996. p. 841-2.
188. Jain R. In situ microencapsulation. Ph.D. dissertation, The University of Rhode Island, Kingston, Rhode Island, 1998.
189. Jain R.A., Rhodes C.T., Railkar A.M., Malick A.W., Shah N.H. Controlled release of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. Pharm Sci Suppl. 1(1):1998;S-298.
190. Jain R.A., Rhodes C.T., Railkar A.M., Malick A.W., Shah N.H. Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres. effect of various formulation variables Pharm Sci Suppl. 1(1):1998;S-412.
191. Jain RA, Rhodes CT, Railkar AM, Malick AW, Shah NH. Comparision of various protein loaded biodegradable PLGA devices. Proceedings of the International Symposium on Control. Rel. Bioact. Mater., vol. 26, 1999.